mTOR Inhibitors in Cancer: What Can We Learn From Exceptional Responses?

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2014.12.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy